Sympathetic Nerve Activity and an Implantable Cardioverter Defibrillator in Heart Failure Patients
Validation of a Prognostic Score to Identify Heart Failure Patients Who Might Need an Implantable Cardioverter Defibrillator Using Muscle Sympathetic Nerve Activity and Autonomic Testing
1 other identifier
observational
109
1 country
1
Brief Summary
The aim of this study is to analyze whether the sympathetic tone, measured indirectly and directly by muscle sympathetic nerve activity recording, is elevated in patients with heart failure receiving an appropriate shock from their implantable cardiac defibrillator (ICD) compared to heart failure patients not receiving a shock from their ICD. All parameters measured in this study will be used to build a risk algorithm able to identify heart failure patients at high risk for sudden cardiac death who could receive an ICD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 23, 2007
CompletedFirst Posted
Study publicly available on registry
February 26, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJune 13, 2012
June 1, 2012
February 23, 2007
June 12, 2012
Conditions
Keywords
Interventions
Microneurography
Eligibility Criteria
Heart failure patient
You may qualify if:
- Heart failure patient with an ICD
You may not qualify if:
- Pregnant patient
- Acute coronary syndrome within the last 3 months
- Peripheral neuropathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiologie, University Hospital
Toulouse, 31400, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Atul Pathak, MD
Hospital University Toulouse
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2007
First Posted
February 26, 2007
Study Start
January 1, 2007
Study Completion
December 1, 2011
Last Updated
June 13, 2012
Record last verified: 2012-06